Disrupting proton dynamics and energy metabolism for cancer therapy

[1]  S. C. Chafe,et al.  Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche , 2013, Oncogene.

[2]  J. Pouysségur,et al.  Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels , 2013, Journal of cellular physiology.

[3]  P. Cozzone,et al.  Quantitative in vivo characterization of intracellular and extracellular pH profiles in heterogeneous tumors: a novel method enabling multiparametric pH analysis. , 2013, Cancer research.

[4]  Christian M. Metallo,et al.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells , 2013, Nature.

[5]  R. Vaughan-Jones,et al.  Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia , 2013, Journal of cellular physiology.

[6]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[7]  M. Pollak.  Targeting oxidative phosphorylation: why, when, and how. , 2013, Cancer cell.

[8]  C. Aalkjaer,et al.  Contribution of Na+,HCO3−‐cotransport to cellular pH control in human breast cancer: A role for the breast cancer susceptibility locus NBCn1 (SLC4A7) , 2013, International journal of cancer.

[9]  Robert J Gillies,et al.  Acidity generated by the tumor microenvironment drives local invasion. , 2013, Cancer research.

[10]  Liu Wei,et al.  LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.

[11]  M. Honavar,et al.  Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. , 2013, Neuro-oncology.

[12]  S. Marcié,et al.  Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis , 2013, Front. Oncol..

[13]  Y. Isaka,et al.  Chloroquine in cancer therapy: a double-edged sword of autophagy. , 2013, Cancer research.

[14]  M. Malumbres,et al.  HIF2α acts as an mTORC1 activator through the amino acid carrier SLC7A5. , 2012, Molecular cell.

[15]  Xuemei Liu,et al.  Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma. , 2012, Carcinogenesis.

[16]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[17]  R. Reithmeier,et al.  Membrane transport metabolons. , 2012, Biochimica et biophysica acta.

[18]  M. Proescholdt,et al.  Function of carbonic anhydrase IX in glioblastoma multiforme. , 2012, Neuro-oncology.

[19]  A. Schwab,et al.  Role of ion channels and transporters in cell migration. , 2012, Physiological reviews.

[20]  Roberto Zoncu,et al.  Amino acids and mTORC1: from lysosomes to disease. , 2012, Trends in molecular medicine.

[21]  Bonnie F. Sloane,et al.  Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. , 2012, Cancer research.

[22]  Robert J Gillies,et al.  Systemic buffers inhibit carcinogenesis in TRAMP mice. , 2012, The Journal of urology.

[23]  P. Codogno,et al.  Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress* , 2012, The Journal of Biological Chemistry.

[24]  R. Gillies,et al.  Evolutionary dynamics of carcinogenesis and why targeted therapy does not work , 2012, Nature Reviews Cancer.

[25]  Albrecht Schwab,et al.  The Na+/H+ exchanger NHE1, but not the Na+, HCO3(-) cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2. , 2012, Cancer letters.

[26]  A. Harris,et al.  Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin , 2012, PloS one.

[27]  J. Pouysségur,et al.  Abstract 3225: Growth inhibition of glycolytic tumors by targeting basigin/lactate-H+ symporters (MCTs): Metformin sensitizes MCT inhibition , 2012 .

[28]  W. Sly,et al.  Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy , 2012, Clinical Cancer Research.

[29]  P. Cozzone,et al.  In vivo pH in metabolic‐defective Ras‐transformed fibroblast tumors: Key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH , 2012, International journal of cancer.

[30]  M. Casal,et al.  Role of monocarboxylate transporters in human cancers: state of the art , 2012, Journal of Bioenergetics and Biomembranes.

[31]  G. Semenza,et al.  Hypoxia-Inducible Factors in Physiology and Medicine , 2012, Cell.

[32]  A. Halestrap.  The monocarboxylate transporter family—Structure and functional characterization , 2012, IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology.

[33]  K. Harper,et al.  Hypoxia-Induced Invadopodia Formation Involves Activation of NHE-1 by the p90 Ribosomal S6 Kinase (p90RSK) , 2011, PloS one.

[34]  J. Pastorek,et al.  Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain* , 2011, The Journal of Biological Chemistry.

[35]  Roberto Zoncu,et al.  mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase , 2011, Science.

[36]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[37]  Claudiu T. Supuran,et al.  Interfering with pH regulation in tumours as a therapeutic strategy , 2011, Nature Reviews Drug Discovery.

[38]  J. Pouysségur,et al.  CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors , 2011, Proceedings of the National Academy of Sciences.

[39]  C. Supuran,et al.  Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. , 2011, Journal of medicinal chemistry.

[40]  P. Sutphin,et al.  Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality , 2011, Science Translational Medicine.

[41]  Karen K. Y. Lam,et al.  Regulation of mTORC1 Signaling by pH , 2011, PloS one.

[42]  W. Sly,et al.  Transport Activity of the High-affinity Monocarboxylate Transporter MCT2 Is Enhanced by Extracellular Carbonic Anhydrase IV but Not by Intracellular Carbonic Anhydrase II* , 2011, Journal of Biological Chemistry.

[43]  P. Lambin,et al.  Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  K. Landfester,et al.  Omeprazole Inhibits Proliferation and Modulates Autophagy in Pancreatic Cancer Cells , 2011, PloS one.

[45]  S. Leung,et al.  Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. , 2011, Cancer Research.

[46]  J. Pouysségur,et al.  Hypoxia and energetic tumour metabolism. , 2011, Current opinion in genetics & development.

[47]  J. Pouysségur,et al.  pH control mechanisms of tumor survival and growth , 2011, Journal of cellular physiology.

[48]  R. McKenna,et al.  Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II , 2011, Proceedings of the National Academy of Sciences.

[49]  C. Stief,et al.  A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients , 2011, World Journal of Urology.

[50]  A. Harris,et al.  New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation , 2010, Oncogene.

[51]  M. Nantz,et al.  Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas , 2010, Brain Research.

[52]  S. Pattingre,et al.  Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells , 2010, Cell Death and Disease.

[53]  J. Nylandsted,et al.  NBCn1 and NHE1 expression and activity in DeltaNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. , 2010, Experimental cell research.

[54]  M. Tresguerres,et al.  Physiological carbon dioxide, bicarbonate, and pH sensing , 2010, Pflügers Archiv - European Journal of Physiology.

[55]  F. Lozupone,et al.  pH‐dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity , 2010, International journal of cancer.

[56]  D. Hailey,et al.  Autophagy termination and lysosome reformation regulated by mTOR , 2010, Nature.

[57]  R. Gatenby,et al.  Proton dynamics in cancer , 2010, Journal of Translational Medicine.

[58]  S. Fais.  Proton pump inhibitor‐induced tumour cell death by inhibition of a detoxification mechanism , 2010, Journal of internal medicine.

[59]  J. Pouysségur,et al.  Hypoxia-induced autophagy: cell death or cell survival? , 2010, Current opinion in cell biology.

[60]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[61]  K. Hahn,et al.  Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling , 2010, The Journal of cell biology.

[62]  W. Boron.  Evaluating the role of carbonic anhydrases in the transport of HCO3--related species. , 2010, Biochimica et biophysica acta.

[63]  G. Semenza,et al.  Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression , 2010, Proceedings of the National Academy of Sciences.

[64]  J. Pouysségur,et al.  Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration. , 2010, Advances in enzyme regulation.

[65]  Sergio Grinstein,et al.  Sensors and regulators of intracellular pH , 2010, Nature Reviews Molecular Cell Biology.

[66]  M. Salto‐Tellez,et al.  Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo. , 2009, Cancer research.

[67]  F. Oswald,et al.  CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in-vivo and in-vitro models , 2009 .

[68]  C. Supuran,et al.  The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms. , 2009, Bioorganic & medicinal chemistry letters.

[69]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[70]  Pawel Swietach,et al.  The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths* , 2009, The Journal of Biological Chemistry.

[71]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[72]  Robert J Gillies,et al.  The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. , 2009, Cancer research.

[73]  Bonnie F. Sloane,et al.  Bicarbonate increases tumor pH and inhibits spontaneous metastases. , 2009, Cancer research.

[74]  N. Philp,et al.  Interaction of Monocarboxylate Transporter 4 with ␤ 1 -integrin and Its Role in Cell Migration , 2022 .

[75]  J. Pouysségur,et al.  Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. , 2009, Cancer research.

[76]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[77]  P. Seglen,et al.  Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? , 2008, Autophagy.

[78]  J. Deitmer,et al.  Nonenzymatic Proton Handling by Carbonic Anhydrase II during H+-Lactate Cotransport via Monocarboxylate Transporter 1* , 2008, Journal of Biological Chemistry.

[79]  A. Harris,et al.  Tumor-associated Carbonic Anhydrase 9 Spatially Coordinates Intracellular pH in Three-dimensional Multicellular Growths* , 2008, Journal of Biological Chemistry.

[80]  G. Buckberg,et al.  Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. , 2008, The Annals of thoracic surgery.

[81]  M. Avkiran,et al.  Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? , 2008, Current opinion in pharmacology.

[82]  Ru Wei,et al.  The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth , 2008, Nature.

[83]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[84]  Robert J. Gillies,et al.  A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.

[85]  G. Malnic,et al.  NHE1, NHE2, and NHE4 contribute to regulation of cell pH in T84 colon cancer cells , 2008, Pflügers Archiv - European Journal of Physiology.

[86]  Michael Forgac,et al.  Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology , 2007, Nature Reviews Molecular Cell Biology.

[87]  P. Maini,et al.  Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer , 2007, British Journal of Cancer.

[88]  P. Matarrese,et al.  Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. , 2007, Cancer research.

[89]  N. Philp,et al.  Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231. , 2007, Cancer research.

[90]  R. Johnson,et al.  ATP6V0C Competes with Von Hippel-Lindau Protein in Hypoxia-Inducible Factor 1α (HIF-1α) Binding and Mediates HIF-1α Expression by Bafilomycin A1 , 2007, Molecular Pharmacology.

[91]  Eugene Y. Kim,et al.  Evidence against a Direct Interaction between Intracellular Carbonic Anhydrase II and Pure C-terminal Domains of SLC4 Bicarbonate Transporters* , 2007, Journal of Biological Chemistry.

[92]  Huaqing Zhao,et al.  The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma , 2006, Molecular Pharmacology.

[93]  G. Semenza,et al.  HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[94]  W. Boron,et al.  Effect of Human Carbonic Anhydrase II on the Activity of the Human Electrogenic Na/HCO3 Cotransporter NBCe1-A in Xenopus Oocytes* , 2006, Journal of Biological Chemistry.

[95]  E. Rofstad,et al.  Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. , 2006, Cancer research.

[96]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[97]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[98]  E. T. Gawlinski,et al.  Acid-mediated tumor invasion: a multidisciplinary study. , 2006, Cancer research.

[99]  A. Halestrap,et al.  The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[100]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[101]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[102]  Daniela Hirnet,et al.  Transport Activity of MCT1 Expressed in Xenopus Oocytes Is Increased by Interaction with Carbonic Anhydrase* , 2005, Journal of Biological Chemistry.

[103]  A. Ross,et al.  Monocarboxylate transporter MCT1 is a target for immunosuppression , 2005, Nature chemical biology.

[104]  Eon J. Rios,et al.  Chronic hypoxia elevates intracellular pH and activates Na+/H+ exchange in pulmonary arterial smooth muscle cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[105]  R. Cardone,et al.  The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis , 2005, Nature Reviews Cancer.

[106]  W. Boron,et al.  Regulation of intracellular pH. , 2004, Advances in physiology education.

[107]  C. Supuran,et al.  Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH , 2004, FEBS letters.

[108]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[109]  S. Gottschalk,et al.  Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells , 2004, Clinical Cancer Research.

[110]  Adrian L Harris,et al.  Role of Carbonic Anhydrase IX in Human Tumor Cell Growth, Survival, and Invasion , 2004, Cancer Research.

[111]  M. Romero,et al.  The SLC26 gene family of multifunctional anion exchangers , 2004, Pflügers Archiv.

[112]  M. Romero,et al.  The SLC4 family of HCO3− transporters , 2004, Pflügers Archiv.

[113]  A. Paradiso,et al.  Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[114]  Jin Hwan Kim,et al.  Proton-sensing G-protein-coupled receptors , 2003 .

[115]  Gregory S Karczmar,et al.  MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.

[116]  U. Rodeck,et al.  Regulation of intracellular pH in human melanoma: potential therapeutic implications. , 2002, Molecular cancer therapeutics.

[117]  J. Casey,et al.  A Transport Metabolon , 2001, The Journal of Biological Chemistry.

[118]  S. McIntire,et al.  A Family of Yeast Proteins Mediating Bidirectional Vacuolar Amino Acid Transport* , 2001, The Journal of Biological Chemistry.

[119]  J. Pouysségur,et al.  pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. , 2001, Novartis Foundation symposium.

[120]  P H Watson,et al.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.

[121]  D. Meredith,et al.  Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle , 2000, The Journal of physiology.

[122]  S. Caldeira,et al.  Na+/H+ exchanger‐dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation‐associated phenotypes , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[123]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.

[124]  A. Barclay,et al.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression , 2000, The EMBO journal.

[125]  O. Garden,et al.  Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)/H(+) exchanger. , 2000, Blood.

[126]  R. Gillies,et al.  pH and drug resistance. I. Functional expression of plasmalemmal V-type H+-ATPase in drug-resistant human breast carcinoma cell lines. , 1999, Biochemical pharmacology.

[127]  Y. Moriyama,et al.  Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. , 1998, Cell structure and function.

[128]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[129]  J. Pouysségur,et al.  Molecular physiology of vertebrate Na+/H+ exchangers. , 1997, Physiological reviews.

[130]  E. T. Gawlinski,et al.  A reaction-diffusion model of cancer invasion. , 1996, Cancer research.

[131]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[132]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[133]  H. Guo,et al.  The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. , 1995, Cancer research.

[134]  A. Halestrap,et al.  N-terminal protein sequence analysis of the rabbit erythrocyte lactate transporter suggests identity with the cloned monocarboxylate transport protein MCT1. , 1994, The Biochemical journal.

[135]  R. Kettmann,et al.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.

[136]  I. Tannock,et al.  Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy. , 1994, British Journal of Cancer.

[137]  Richard G. W. Anderson,et al.  Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: Implications for the Cori cycle , 1994, Cell.

[138]  Y. Moriyama,et al.  Evidence for a common binding site for omeprazole and N-ethylmaleimide in subunit A of chromaffin granule vacuolar-type H(+)-ATPase. , 1993, Biochemical and biophysical research communications.

[139]  R. Gillies,et al.  Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. , 1993, The American journal of physiology.

[140]  A. Halestrap,et al.  Transport of lactate and other monocarboxylates across mammalian plasma membranes. , 1993, The American journal of physiology.

[141]  K. Väänänen,et al.  Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases. , 1991, Biochimica et biophysica acta.

[142]  P. Okunieff,et al.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.

[143]  I. Tannock,et al.  Reduction of intracellular pH as a possible mechanism for killing cells in acidic regions of solid tumors: effects of carbonylcyanide-3-chlorophenylhydrazone. , 1989, Cancer research.

[144]  J. Davoust,et al.  Low cytoplasmic pH inhibits endocytosis and transport from the trans- Golgi network to the cell surface , 1989, The Journal of cell biology.

[145]  C. Sardet,et al.  Molecular cloning, primary structure, and expression of the human growth factor-activatable Na+ H+ , 1989, Cell.

[146]  S Grinstein,et al.  Requirement of the Na + / H + Exchanger for Tumor Growth 1 , 2006 .

[147]  I. Tannock,et al.  Cytotoxicity of compounds that interfere with the regulation of intracellular pH: a potential new class of anticancer drugs. , 1987, Cancer research.

[148]  J. Pouysségur,et al.  Intracellular pH controls growth factor-induced ribosomal protein S6 phosphorylation and protein synthesis in the G0----G1 transition of fibroblasts. , 1986, Experimental cell research.

[149]  I. Tannock,et al.  Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors. , 1986, Cancer research.

[150]  J. Pouysségur,et al.  Cytoplasmic pH, a key determinant of growth factor‐induced DNA synthesis in quiescent fibroblasts , 1985, FEBS letters.

[151]  H. Lodish,et al.  Primary structure and transmembrane orientation of the murine anion exchange protein , 1985, Nature.

[152]  J. Haveman,et al.  The relevance of tumour pH to the treatment of malignant disease. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[153]  C. Sardet,et al.  A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[154]  J. Pouysségur,et al.  Growth factor action and intracellular pH regulation in fibroblasts. Evidence for a major role of the Na+/H+ antiport. , 1984, The Journal of biological chemistry.

[155]  J. Pouysségur,et al.  Biochemical characterization of the amiloride-sensitive Na+/H+ antiport in Chinese hamster lung fibroblasts. , 1983, The Journal of biological chemistry.

[156]  O. Andersen,et al.  Chloride--bicarbonate exchange in red blood cells: physiology of transport and chemical modification of binding sites. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[157]  P. Aronson,et al.  Modifier role of internal H+ in activating the Na+–H+ exchanger in renal microvillus membrane vesicles , 1982, Nature.

[158]  J. Pouysségur,et al.  Growth factor activation of an amiloride-sensitive Na+/H+ exchange system in quiescent fibroblasts: coupling to ribosomal protein S6 phosphorylation. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[159]  W. Boron,et al.  Intracellular pH. , 1981, Physiological reviews.

[160]  I. Cameron,et al.  Cellular potentials of normal and cancerous fibroblasts and hepatocytes. , 1980, Cancer research.

[161]  D. Epel,et al.  Intracellular pH and activation of sea urchin eggs after fertilisation , 1976, Nature.

[162]  D. Burk,et al.  On respiratory impairment in cancer cells. , 1956, Science.

[163]  H. Kahler,et al.  THE ESTIMATION OF THE HYDROGEN-ION CONCENTRATION OF THE TISSUES IN LIVING ANIMALS. , 1932, Science.

[164]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[165]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.